Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS

Autor: Bafadhel M, Rabe KF, Martinez FJ, Singh D, Darken P, Jenkins M, Aurivillius M, Patel M, Dorinsky P

Publikováno v: International Journal of COPD, Vol Volume 17, Pp 3061-3073 (2022)

Mona Bafadhel,1 Klaus F Rabe,2 Fernando J Martinez,3 Dave Singh,4 Patrick Darken,5 Martin Jenkins,6 Magnus Aurivillius,7 Mehul Patel,6 Paul Dorinsky8 1Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences

Externí odkaz: https://doaj.org/article/01954588a7184f5ab3f055fc7bc4027b

Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS

Autor: Martinez FJ, Ferguson GT, Bourne E, Ballal S, Darken P, Aurivillius M, Dorinsky P, Reisner C

Publikováno v: International Journal of COPD, Vol Volume 16, Pp 179-189 (2021)

Fernando J Martinez,1 Gary T Ferguson,2 Eric Bourne,3 Shaila Ballal,4 Patrick Darken,5 Magnus Aurivillius,6 Paul Dorinsky,3 Colin Reisner4 1Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA; 2Pulmonary Resear

Externí odkaz: https://doaj.org/article/9b5593e4a9d54ffa81f14ea01fd6ef3f

Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

Autor: Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 2993-3002 (2019)

Masakazu Ichinose,1 Yasushi Fukushima,2 Yoshikazu Inoue,3 Osamu Hataji,4 Gary T Ferguson,5 Klaus F Rabe,6 Nobuya Hayashi,7 Hiroshi Okada,7 Mami Takikawa,7 Eric Bourne,8 Shaila Ballal,9 Kiernan DeAngelis,10 Magnus Aurivillius,11 Colin Reisner,9 Paul D

Externí odkaz: https://doaj.org/article/262f6a797cf44bc698a4286f38fb9c79

Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD

Autor: Rabe, K. F., Martinez, F. J., Ferguson, G. T., Wang, C., Singh, D., Wedzicha, J. A., Trivedi, R., t. Rose E., S, Ballal, S., Mclaren, J., Darken, P., Aurivillius, M., Reisner, C., Dorinsky, P., Spanevello, A.

Publikováno v: Rabe, K F, Martinez, F J, Ferguson, G T, Wang, C, Singh, D, Wedzicha, J A, Trivedi, R, St. Rose, E, Ballal, S, Mclaren, J, Darken, P, Aurivillius, M, Reisner, C & Dorinsky, P 2020, ' Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD ', New England Journal Of Medicine, vol. 383, no. 1, pp. 35-48 . https://doi.org/10.1056/NEJMoa1916046

BACKGROUND Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive pulmonary disease (COPD) have been studied at single dose levels of inhaled g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df6acf5d9a0dcfc420dc8a0e8f3fa8f
http://hdl.handle.net/11383/2132038

L’inhalateur-doseur de budésonide/glycopyrrolate/formotérol fumarate, formulé avec une technologie de délivrance de co-suspension, améliore la fonction pulmonaire et les taux d’exacerbations chez les patients atteints de BPCO sans antécédents récents d’exacerbations : analyse post-hoc de l’étude KRONOS

Autor: Martinez, F.J., Ferguson, G.T., Bourne, E., Ballal, S., Darken, P., Deangelis, K., Aurivillius, M., Dorinsky, P., Reisner, C.

Publikováno v: In Revue des Maladies Respiratoires Actualités January 2020 12(1):192-192